Literature DB >> 15322540

Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization.

Till A Röhn1, Marianne Boes, Dirk Wolters, Sebastian Spindeldreher, Bernd Müller, Hanno Langen, Hidde Ploegh, Anne B Vogt, Harald Kropshofer.   

Abstract

Dendritic cells (DCs) initiate and regulate immunity against foreign and self antigens. Here we identified more than 200 individual major histocompatibility complex class II-associated peptides on human DCs and found that mature DCs selectively upregulated the self peptide CLIP. CLIP cosegregated together with foreign antigenic peptides in tetraspan microdomains on the surface and localized to DC-T cell synapses. The increased representation of CLIP-major histocompatibility complex class II complexes favored polarization of autologous naive T cells toward the nonpolarized and T helper type 2 (T(H)2) phenotype. There was also a considerably higher T(H)2/T(H)1 ratio in H2-DM-deficient mice, which have a CLIP(hi) phenotype, in contrast to wild-type, CLIP(lo) mice. Thus, the self peptide CLIP on DCs qualifies as an endogenous regulator in priming of T helper cells by antagonizing the polarization toward the T(H)1 phenotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322540     DOI: 10.1038/ni1108

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  18 in total

1.  The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity.

Authors:  Cristina C Clement; Aniuska Becerra; Liusong Yin; Valerio Zolla; Liling Huang; Simone Merlin; Antonia Follenzi; Scott A Shaffer; Lawrence J Stern; Laura Santambrogio
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

2.  The tetraspanin CD9 mediates lateral association of MHC class II molecules on the dendritic cell surface.

Authors:  Julia J Unternaehrer; Amy Chow; Marc Pypaert; Kayo Inaba; Ira Mellman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-26       Impact factor: 11.205

3.  A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance.

Authors:  Arthur A Vandenbark; Roberto Meza-Romero; Gil Benedek; Shayne Andrew; Jianya Huan; Yuan K Chou; Abigail C Buenafe; Rony Dahan; Yoram Reiter; Jeffery L Mooney; Halina Offner; Gregory G Burrows
Journal:  J Autoimmun       Date:  2012-09-29       Impact factor: 7.094

Review 4.  Pathways of antigen processing.

Authors:  Janice S Blum; Pamela A Wearsch; Peter Cresswell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

5.  Bidirectional binding of invariant chain peptides to an MHC class II molecule.

Authors:  Sebastian Günther; Andreas Schlundt; Jana Sticht; Yvette Roske; Udo Heinemann; Karl-Heinz Wiesmüller; Günther Jung; Kirsten Falk; Olaf Rötzschke; Christian Freund
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-29       Impact factor: 11.205

Review 6.  The immune system as a self-centered network of lymphocytes.

Authors:  Fabio R Santori
Journal:  Immunol Lett       Date:  2015-06-16       Impact factor: 3.685

7.  MHC class I and II peptide homology regulates the cellular immune response.

Authors:  Matthew M Halpert; Vanaja Konduri; Dan Liang; Jonathan Vazquez-Perez; Colby J Hofferek; Scott A Weldon; Yunyu Baig; Indira Vedula; Jonathan M Levitt; William K Decker
Journal:  FASEB J       Date:  2020-04-16       Impact factor: 5.191

Review 8.  HLA-DR: molecular insights and vaccine design.

Authors:  Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Vaccinia peptides eluted from HLA-DR1 isolated from virus-infected cells are recognized by CD4+ T cells from a vaccinated donor.

Authors:  Iwona Strug; J Mauricio Calvo-Calle; Karin M Green; John Cruz; Francis A Ennis; James E Evans; Lawrence J Stern
Journal:  J Proteome Res       Date:  2008-05-29       Impact factor: 4.466

10.  Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells.

Authors:  Jacobus J Bosch; Uzoma K Iheagwara; Sarah Reid; Minu K Srivastava; Julie Wolf; Michal Lotem; Bruce R Ksander; Suzanne Ostrand-Rosenberg
Journal:  Cancer Immunol Immunother       Date:  2009-06-26       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.